UPCOMING WEBINAR: Utilization of PET/CT in Gastrointestinal Cancers

Presenter: Robert S. Bridwell, MD, MBA

Date: March 20, 2019

Time: 3:00pm EST

Who should attend? PET Interpreters, Technologists, Referring Physicians, Marketers

Dr. Robert Bridwell, medical advisor to SOFIE, and co-founder of PETLinQ, is a board-certified physician in both Internal Medicine and Nuclear Medicine. He has extensive knowledge and experience in continuous quality improvement programs for PET and PET/CT imaging, utilizing physician empowerment training, protocol development assistance, and quality assurance guidelines. In the last five years, Dr. Bridwell has been invited to make numerous presentations, which have included more than 1200 hours of CME credit delivered to more than 350 institutions, 100 professional society meetings and more than 150 radiology groups throughout the United States, Canada and Europe.

In this session, Dr. Bridwell will:

• Review the key facts regarding Gastrointestinal cancers, including the types, U.S. incidence and prevalence, typical disease work-up and range of treatments

• Describe the specific role that PET/CT imaging has in the staging, response to therapy and restaging / recurrence of Gastrointestinal cancers

• Identify the limitations and pitfalls, including potential false positives and false negatives, of PET/CT imaging specific for these oncologic indications

• Utilize recent scientific studies to support the appropriate use of PET/CT imaging for these indications

Register now to receive weblink: https://attendee.gotowebinar.com/register/7882190348515542531

NewsSeth Werkheiser